Home / UK and US child vaccine schedules, side by side

UK and US child vaccine schedules, side by side

Your child had vaccines in the UK. This page quotes what the UK Health Security Agency and CDC each publish, dated, in two columns, then the records route in the United States. It does not say which doses your child still needs.

United Kingdom: UK Health Security Agency

Document: gov.uk page last updated 24 Sep 2026.

The gov.uk page for the schedule is addressed to health professionals and immunisation practitioners; it was last updated 24 September 2026 and carries the schedule "from 1 September 2026".

Some UK entries repeat instructions written for the clinician giving the vaccine; they are quoted as the UKHSA prints them, not as advice to parents.

  • From 1 January 2026 the MMRV vaccine is offered as part of the updated routine schedule, with an appointment at 18 months
  • At eight weeks old the schedule lists DTaP/IPV/Hib/HepB (diphtheria, tetanus, pertussis, polio, Hib, hepatitis B; Infanrix hexa or Vaxelis, thigh), MenB (Bexsero, thigh) and rotavirus (Rotarix, by mouth; check the SCID screening result before giving)
  • At twelve weeks old the schedule lists DTaP/IPV/Hib/HepB (Infanrix hexa or Vaxelis, thigh), MenB (Bexsero, thigh) and rotavirus (Rotarix, by mouth; check the SCID screening result before giving)
  • At sixteen weeks old the schedule lists DTaP/IPV/Hib/HepB (Infanrix hexa or Vaxelis, thigh) and pneumococcal, 13 serotypes (PCV, Prevenar 13, thigh)
  • At one year old (on or after the first birthday) the schedule lists pneumococcal (PCV, Prevenar 13), MenB (Bexsero) and measles, mumps, rubella, varicella (MMRV, ProQuad or Priorix Tetra); upper arm or thigh
  • At eighteen months old, for children born on or after 1 July 2024 the schedule lists DTaP/IPV/Hib/HepB (Infanrix hexa or Vaxelis) and MMRV (ProQuad or Priorix Tetra), upper arm or thigh; for children born on or before 30 June 2024 it says "No appointment"
  • At three years four months old or soon after, for children born on or after 1 January 2025 the schedule lists dTaP/IPV (REPEVAX; diphtheria, tetanus, pertussis and polio); for children born on or before 31 December 2024 it lists dTaP/IPV and MMRV (REPEVAX; ProQuad or Priorix Tetra); upper arm
  • Boys and girls aged twelve to thirteen years: HPV vaccine (Gardasil 9; cancers and genital warts caused by specific HPV types), upper arm
  • At fourteen years old (school Year 9): Td/IPV (check MMR status; REVAXIS) and MenACWY (MenQuadfi), upper arm
  • Influenza: an "eligible paediatric age group" is listed for the live attenuated influenza vaccine (Fluenz, both nostrils), each year from September, with inactivated flu vaccine if LAIV is contraindicated or unsuitable (check Green Book Chapter 19 for details); Fluenz is marked as containing porcine gelatine; the page sends readers to the annual flu letter for which ages
  • Selective programmes for infants: hepatitis B at birth and four weeks for babies born to women with hepatitis B infection (Engerix B/HBvaxPRO; for these babies take blood for HBsAg anytime between 12 and 18 months to test for infection, and hexavalent vaccine (Infanrix hexa or Vaxelis) is given in addition at 8, 12 and 16 weeks and also at 18 months); BCG within 28 days of birth for infants in areas with TB incidence of 40 per 100,000 or more, and for infants with a parent or grandparent born in a high incidence country (check the SCID screening outcome before giving BCG); "high incidence" means annual TB incidence of 40 per 100,000 or more

Source: gov.uk

United States: cdc.gov

Document: cdc.gov schedule page headed “Addendum updated July 2, 2025”; the rows quoted here are selected visits, from birth to the 4 to 6 years visit, and the page also carries older ages.

CDC’s note on the page

“Pursuant to the preliminary order issued on March 16, 2026, in American Academy of Pediatrics et al. v. Kennedy et al., No. 1:25-cv-11916 (D. Mass.), which stayed all votes taken by the ACIP during its June, September and December 2025 meetings, and further stayed the Acting CDC Director’s January 5, 2026 Decision Memo revising the CDC’s childhood immunization schedule, the July 2, 2025 immunization schedule posted here is the current CDC Child and Adolescent Immunization Schedule by Age for Healthcare Professionals.”

  • At birth, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 1st dose; RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page. (The page's other bar types are not listed here.)
  • At 1 month, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 2nd dose; RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page. (The page's other bar types are not listed here.)
  • At 2 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 2nd dose; RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page; Rotavirus: 1st dose; DTaP (diphtheria, tetanus, whooping cough): 1st dose; Hib: 1st dose; Pneumococcal conjugate: 1st dose; Polio (IPV): 1st dose; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
  • At 4 months, the cdc.gov table marks as routine, risk-based or shared decision: RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page; Rotavirus: 2nd dose; DTaP (diphtheria, tetanus, whooping cough): 2nd dose; Hib: 2nd dose; Pneumococcal conjugate: 2nd dose; Polio (IPV): 2nd dose; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
  • At 6 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 3rd dose; RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page (only part of the bar is this category; see the page); RSV antibody: certain high-risk groups (only part of the bar is this category; see the page); Rotavirus: see the notes on the page; DTaP (diphtheria, tetanus, whooping cough): 3rd dose; Hib: see the notes on the page; Pneumococcal conjugate: 3rd dose; Polio (IPV): 3rd dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; MMR (measles, mumps, rubella): certain high-risk groups, see the notes on the page; Hepatitis A: certain high-risk groups, see the notes on the page; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
  • At 12 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 3rd dose; RSV antibody: certain high-risk groups: 1 dose (8 through 19 months), see the notes on the page; Hib: 3rd or 4th dose, see the notes on the page; Pneumococcal conjugate: 4th dose; Polio (IPV): 3rd dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; MMR (measles, mumps, rubella): 1st dose; Chickenpox (varicella): 1st dose; Hepatitis A: 2-dose series, see the notes on the page; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
  • At 15 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 3rd dose; RSV antibody: certain high-risk groups: 1 dose (8 through 19 months), see the notes on the page; DTaP (diphtheria, tetanus, whooping cough): 4th dose; Hib: 3rd or 4th dose, see the notes on the page; Pneumococcal conjugate: 4th dose; Polio (IPV): 3rd dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; MMR (measles, mumps, rubella): 1st dose; Chickenpox (varicella): 1st dose; Hepatitis A: 2-dose series, see the notes on the page; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
  • At 18 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 3rd dose; RSV antibody: certain high-risk groups: 1 dose (8 through 19 months), see the notes on the page; DTaP (diphtheria, tetanus, whooping cough): 4th dose; Polio (IPV): 3rd dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; Hepatitis A: 2-dose series, see the notes on the page; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
  • At 4 to 6 years, the cdc.gov table marks as routine, risk-based or shared decision: DTaP (diphtheria, tetanus, whooping cough): 5th dose; Hib: certain high-risk groups (only part of the bar is this category; see the page); Pneumococcal conjugate: certain high-risk groups (only part of the bar is this category; see the page); Polio (IPV): 4th dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; MMR (measles, mumps, rubella): 2nd dose; Chickenpox (varicella): 2nd dose; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)

Source: cdc.gov

The schedules are not meant to be read against each other dose by dose. Bring the original record to your child’s doctor or nurse.

The cdc.gov column is the schedule CDC publishes today, as dated above. The AAP publishes a different schedule, and the two differ for some vaccines: see CDC and AAP compared.

Records and who to ask

Vaccination records: the NHS red book

School entry

Each state sets its own list: see school vaccine rules and shot records by state.

Urgent care

US emergency medical services (MedlinePlus) is the page of the US National Library of Medicine. This site does not give medical advice.

Everything on this page was checked against its source on or after 12 Nov 2026. Each column shows its own document date.

See also the AAP schedule by visit and US state rules.